Nora Nikolac Gabaj

Prof. Nora Nikolac Gabaj

University Department of Chemistry, Medical School University Hospital Sestre Milosrdnice, Zagreb, Croatia
+1

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Biochemia Medica
Verified
Journal Article
Open access
NGNora Nikolac Gabaj
Nora Nikolac Gabaj
In the clinical laboratory setting, interferences can be a significant source of laboratory errors with potential to cause serious harm for the patient. After hemolysis, lipemia is the most frequent endogenous interference that can influence results of various laboratory methods by several mechanisms. The most common preanalytical cause of lipemic samples is inadequate time of blood sampling after the meal or parenteral administration of synthetic lipid emulsions. Although the best way of detecting the degree of lipemia is measuring lipemic index on analytical platforms, laboratory experts should be aware of its problems, like false positive results and lack of standardization between manufacturers. Unlike for other interferences, lipemia can be removed and measurement can be done in a clear sample. However, a protocol for removing lipids from the sample has to be chosen carefully, since it is dependent on the analytes that have to be determined. Investigation of lipemia interference is an obligation of manufacturers of laboratory reagents; however, several literature findings report lack of verification of the declared data. Moreover, the acceptance criteria currently used by the most manufacturers are not based on biological variation and need to be revised. Written procedures for detection of lipemia, removing lipemia interference and reporting results from lipemic samples should be available to laboratory staff in order to standardize the procedure, reduce errors and increase patient safety.

16 October 2012 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Open access
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi
KBKathleen Becan-McBride
Kathleen Becan-McBride
DBDarina Behúlová
Darina Behúlová
RBRaffick A. Bowen
Raffick A. Bowen
SCStephen Church
Stephen Church
AŠAna-Maria Šimundić
Ana-Maria Šimundić
Total quality in laboratory medicine should be defined as the guarantee that each activity throughout the total testing process is correctly performed, providing valuable medical decision-making and effective patient care. In the past decades, a 10-fold reduction in the analytical error rate has been achieved thanks to improvements in both reliability and standardization of analytical techniques, reagents, and instrumentation. Notable advances in information technology, quality control and quality assurance methods have also assured a valuable contribution for reducing diagnostic errors. Nevertheless, several lines of evidence still suggest that most errors in laboratory diagnostics fall outside the analytical phase, and the pre- and postanalytical steps have been found to be much more vulnerable. This collective paper, which is the logical continuum of the former already published in this journal 2 years ago, provides additional contribution to risk management in the preanalytical phase and is a synopsis of the lectures of the 2nd European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)-Becton Dickinson (BD) European Conference on Preanalytical Phase meeting entitled “Preanalytical quality improvement: in quality we trust” (Zagreb, Croatia, 1–2 March 2013). The leading topics that will be discussed include quality indicators for preanalytical phase, phlebotomy practices for collection of blood gas analysis and pediatric samples, lipemia and blood collection tube interferences, preanalytical requirements of urinalysis, molecular biology hemostasis and platelet testing, as well as indications on best practices for safe blood collection. Auditing of the preanalytical phase by ISO assessors and external quality assessment for preanalytical phase are also discussed.

1 November 2008 in Clinical Biochemistry
Verified
Journal Article
Closed access
VKVanja Basic Kes
Vanja Basic Kes
AŠAna-Maria Šimundić
Ana-Maria Šimundić
NGNora Nikolac Gabaj
Nora Nikolac Gabaj
ETElizabeta Topic
Elizabeta Topic
VDVida Demarin
Vida Demarin

1 January 2009 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
AŠAna-Maria Šimundić
Ana-Maria Šimundić
NGNora Nikolac Gabaj
Nora Nikolac Gabaj
VIValentina Ivankovic
Valentina Ivankovic
DFDragica Ferenec-Ruzic
Dragica Ferenec-Ruzic
BMBojana Magdic
Bojana Magdic
ETElizabeta Topic
Elizabeta Topic
Results from hemolyzed, icteric, and lipemic samples may be inaccurate and can lead to medical errors. These preanalytical interferences may be detected using visual or automated assessment. Visual inspection is time consuming, highly subjective and not standardized. Our aim was to assess the comparability of automated spectrophotometric detection and visual inspection of lipemic, icteric and hemolyzed samples. This study was performed on 1727 routine biochemistry serum samples. Automated detection was performed using the Olympus AU2700 analyzer. We assessed: 1) comparability of visual and automated detection of lipemic, icteric and hemolyzed samples, 2) precision of automated detection, and 3) inter-observer variability for visual inspection. Weighted kappa coefficients for comparability of visual and automated detection were: 0.555, 0.529 and 0.638, for lipemic, icteric and hemolyzed samples, respectively. The precision for automated detection was high for all interferences, with the exception of samples being only slightly lipemic. The best overall agreement between observers was present in assessing lipemia (mean weighted kappa=0.698), whereas the lowest degree of agreement was observed in assessing icterus (mean weighted kappa=0.476). Visual inspection of lipemic, icteric and hemolyzed samples is highly unreliable and should be replaced by automated systems that report serum indices.

1 January 2013 in Biochemia Medica
Verified
Journal Article
Open access
NGNora Nikolac Gabaj
Nora Nikolac Gabaj
VŠVesna Šupak-Smolčić
Vesna Šupak-Smolčić
AŠAna-Maria Šimundić
Ana-Maria Šimundić
IĆIvana Ćelap
Ivana Ćelap
Phlebotomy is one of the most complex medical procedures in the diagnosis, management and treatment of patients in healthcare. Since laboratory test results are the basis for a large proportion (60–80%) of medical decisions, any error in the phlebotomy process could have serious consequences. In order to minimize the possibility of errors, phlebotomy procedures should be standardised, well-documented and written instructions should be available at every workstation. Croatia is one of the few European countries that have national guidelines for phlebotomy, besides the universally used CLSI (Clinical Laboratory Standards Institute) H3-A6 Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; approved Standard-Sixth Edition (CLSI, 2007) and WHO (World Health Organization) guidelines on drawing blood: best practices in phlebotomy (WHO, 2010). However, the growing body of evidence in importance of preanalytical phase management resulted in a need for evidence based revision and expansion of existing recommendations.

1 January 2010 in Biochemia Medica
Verified
Journal Article
Open access
AŠAna-Maria Šimundić
Ana-Maria Šimundić
ETElizabeta Topic
Elizabeta Topic
NGNora Nikolac Gabaj
Nora Nikolac Gabaj
GLGiuseppe Lippi
Giuseppe Lippi
Detection and management of hemolysis